Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.76−0.25 (-12.44%)
Close on Nov 20, 2026Market cap $104.25MP/E –Yield –
Adagene shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 59M, up 4.8% from the year before. The highest annual figure on record is 59M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 59M | +4.8% |
| FY2024 | Dec 31, 2024 | 56M | +2.8% |
| FY2023 | Dec 31, 2023 | 55M | -0.9% |
| FY2022 | Dec 31, 2022 | 55M | +10.4% |
| FY2021 | Dec 31, 2021 | 50M | +213.7% |
| FY2020 | Dec 31, 2020 | 16M | +5.1% |
| FY2019 | Dec 31, 2019 | 15M | +0.1% |
| FY2018 | Dec 31, 2018 | 15M | – |
See a number that looks wrong?